S
SCM Lifescience
SCM Lifescience is engaged in the research and development of medicines, hair care medicines, stem cell products
About SCM Lifescience
SCM Lifescience is a biotechnology company specializing in the development of advanced stem cell therapies. The company focuses on creating personalized medicine solutions by leveraging cutting-edge metabolomics and ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. SCM Lifescience primarily serves the healthcare sector, targeting patients with chronic and degenerative diseases. Operating in the global biotechnology market, the company employs a business model centered around research and development, clinical trials, and eventual commercialization of its proprietary stem cell therapies. Revenue is generated through partnerships, licensing agreements, and direct sales of its therapeutic products. The company is committed to innovation and scientific excellence, aiming to improve patient outcomes through personalized and effective treatments.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Incheon, South Korea
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 36.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Investment activity
- 1 company, latest Jun 2021
- Capital deployed
- $32M
- Preferred round
- SERIES A
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2025 | $6.7M | — | East Gate Partners | ↗ |
| SERIES C✓Equity / VC | Sep 2018 | $35M | $140M | DS Asset Management · Neoplux | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for SCM Lifescience is 1.9K monthly website visits, down 81% over the last three months. SCM Lifescience's team declined 8.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
DS Asset Management
Neoplux
Other known investors2 additional known investors
East Gate Partners- IUInha University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SCM Lifescience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SCM Lifescience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.